3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
18
Uveal Melanoma
4
Prostatic Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Sarcoma
2
Salivary Gland Neoplasms
2
Recurrent Squamous Cell Lung Carcinoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Leukemia, Hairy Cell
2
Leukemia, Biphenotypic, Acute
2
Intraocular Lymphoma
2
Hodgkin Disease
2
Brain Neoplasms
2
Anus Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Interventions
Paclitaxel
4
pembrolizumab
2
pazopanib
2
efatutazone
2
Sorafenib
2
Radiotherapy, Intensity-Modulated
2
trametinib
1
tislelizumab
1
surufatinib
1
spartalizumab
1
sapanisertib
1
lenvatinib
1
fosbretabulin
1
dabrafenib
1
crolibulin
1
combretastatin
1
cabozantinib
1
atezolizumab
1
abemaciclib
1
Taxes
1
Imatinib Mesylate
1
Gefitinib
1
Doxorubicin
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
CUDC-907
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thyroid Carcinoma, Anaplastic
×
CTLA-4 Antigen
×
Clear all
No trials found.